GlaxoSmithKline News

GlaxoSmithKline | F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 25 14:04 ET

GlaxoSmithKline | EFFECT: Others

Mar 16, 2023 00:15 ET

GlaxoSmithKline | 424B3: Prospectus

May 17, 2022 16:36 ET

GlaxoSmithKline | 424B3: Prospectus

May 17, 2022 16:33 ET

GlaxoSmithKline | F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 26, 2021 13:32 ET

GlaxoSmithKline | 8-A12B: Registration of a class of securities on a national securities exchange

Oct 1, 2020 14:52 ET

GlaxoSmithKline | 424B2: Prospectus

Sep 30, 2020 10:56 ET

GlaxoSmithKline | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Sep 28, 2020 16:24 ET

GlaxoSmithKline | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Sep 28, 2020 16:22 ET

GlaxoSmithKline | 424B2: Prospectus

Sep 28, 2020 09:30 ET

GlaxoSmithKline | EFFECT: Others

Jul 30, 2019 00:15 ET

GlaxoSmithKline | 8-A12B: Registration of a class of securities on a national securities exchange

Mar 25, 2019 13:54 ET

GlaxoSmithKline | 424B2: Prospectus

Mar 20, 2019 13:55 ET

GlaxoSmithKline | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Mar 18, 2019 18:39 ET

GlaxoSmithKline | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Mar 18, 2019 18:37 ET

GlaxoSmithKline | 424B2: Prospectus

Mar 18, 2019 09:29 ET

GlaxoSmithKline | 8-A12B: Registration of a class of securities on a national securities exchange

May 15, 2018 17:25 ET

GlaxoSmithKline | 8-A12B: Registration of a class of securities on a national securities exchange

May 15, 2018 17:20 ET

GlaxoSmithKline | 424B2: Prospectus

May 14, 2018 17:30 ET

GlaxoSmithKline | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

May 11, 2018 09:17 ET